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Cancer is a leading cause of global childhood mortality from
noncommunicable diseases, affecting approximately 300000
children/adolescents (0-19 years old) annually.1 Of these chil-
dren/adolescents, approximately 89% live in low- and middle-income
countries (LMIC) with an average 30% estimated survival rate, less
than half the rate in high-income countries (HIC).2 This inequality
galvanized the launch of the World Health Organization (WHO)
Global Initiative for Childhood Cancer in September 2018 to improve
survival rates to 60%by 2030.3 WHOhas designated 2020 as the Year
of the Nurse and Midwife and highlights that nurses, together with
midwives, constitute the largest group of health workers4; therefore,
strengthening nursing is critical to meeting this target.
AlthoughWHO initiatives for nursing have generally prioritized pri-
mary care,5 the Global Initiative for Childhood Cancer is aiming for
highly specialized care in LMIC. To achieve the 2030 target, implemen-
tation and scale-up require recognizing the needs and capacities of
Abbreviations: HIC, high-income countries; LMIC, low- andmiddle-income countries; PODC, Paediatric Oncology Developing Countries; PPE, personal protective equipment; SIOP, International
Society of Paediatric Oncology;WHO,World Health Organization.
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health professionals, including nurses. Nurses in LMIC are frequently
exposed to occupational hazards due to work environments that lack
the required resources for safe care, such as personal protective equip-
ment (PPE) for handling chemotherapy.6,7 The absence of special-
ized education, coupled with frequent rotation of trained staff, leaves
nurses ill-equipped to safely deliver care for children/adolescents with
cancer.8 The Nurse Specialists of the Global Initiative for Childhood
Cancer join public calls for all nurses (particularly those in resource-
limited settings), to be provided with protection when managing haz-
ardous drugs as well as oncology specialization training to ensure
optimal nursing care.9–11
It is an ethical imperative that nurses are strengthened and
equipped with knowledge and skills required to care for this vul-
nerable population and provided a safe environment for doing so.
Baseline standards for the provision of safe and effective nurs-
ing care in LMIC have been published by the Paediatric Oncology
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TABLE 1 International Society of Paediatric Oncology (SIOP)
Pediatric Oncology in Developing Countries (PODC) baseline nursing
standards for paediatric oncology in low- andmiddle-income
countries12
Baseline nursing
standards Description of what is needed
1. Inpatient staffing
plans
Nurse-to-patient ratios at different care
levels:
• Oncology inpatient: 1 nurse to
≤ 5 patients
• Bonemarrow transplant: 1 nurse to≤ 2
patients






≥ 2weeks theory/clinical skills training
Learning objectives
Knowledge/skills validation
≥ 3 to 4weeks clinical preceptorship
3. Continuing education ≥ 10 hours/year/nurse
4.Multidisciplinary
teamwork









• If chemo prepared by nurse, biosafety
cabinet, andmedical screening available
6. Evidence-based
nursing policies
Inpatient and outpatient pediatric oncology
nursing policies
Developing Countries (PODC) Nursing Working Group of the
International Society for Paediatric Oncology (SIOP).12 The standards
provide a framework for promoting a positive practice environment
for care delivery (Table 1) and have received widespread endorsement
(https://siop-online.org/baseline-nursing-standards/).
1 SAFE WORKING ENVIRONMENT
Chemotherapy is a standard treatment required to cure most child-
hood cancers. Nurses, pharmacists, and physicians who prepare
chemotherapy,13,14 as well as hospital support personnel (e.g., clean-
ers and waste management staff) and families who are exposed to
chemotherapy and hazardous waste, face immediate and long-term
health risks, including cancer,miscarriages, and infertility.15,16 Adverse
effects from hazardous drug exposure are entirely preventable with
proper use of PPE for chemotherapy administration and biosafety
cabinets for preparation, especially in settings without closed sys-
tem transfer devices for chemotherapy administration as mandated in
manyHIC.17,18
Cost and supply chain challenges can be major barriers to reliable
availability of essential devices and technology in LMIC.19 Nonethe-
less, the cost of securing PPE for safe handling of chemotherapy and
hazardous drugs and materials is minimal in comparison with other
costs of scaling up cancer treatment.20 It is not ethically defendable
to invest in contemporary pediatric cancer treatment while failing
to protect nurses and other health professionals from avoidable
health risks in their work environments as recommended in numerous
international guidelines.11,18 Given that PPE has been secured for
infectious disease management (e.g., Ebola21) and other public health
threats,22,23 obtaining these resources to deliver chemotherapy safely
is surely achievable.
There has been a persistent failure in LMIC to ensure access to
PPE for safe preparation, administration, and disposal of chemother-
apy for nurses,8 pharmacists, and physicians.14,24 This includes
chemotherapy-tested gloves, masks, protective eyewear and dispos-
able impermeable gowns,11 and at minimum, a level 2B biosafety cab-
inet with appropriate ventilation.25 There is also a lack of appropri-
ate training for health professionals in safe handling practices,26,27
although there are increasing efforts to address this.28,29
2 SPECIALIZED PEDIATRIC ONCOLOGY
NURSES
Investing in healthworkforce specialized education and training is sup-
ported byWHOEducationGuidelines.30 Given the complexity of pedi-
atric cancer diagnoses, treatment, and care, nurses require specialized
education and clinical training to deliver safe, quality care and reduce
risk for patient harm.10,31 Specialized nursing education in all settings
where children/adolescents with cancer are cared for, including oper-
ating rooms and intensive care units, improves quality and outcomes
while strengthening broader health services.32
Many train-the-trainer programs in pediatric oncology nursing have
been conducted since the1990s.However, fewof these programshave
established sustained specialized nursing education in either an in-
country school of nursing or a hospital clinical setting, although suc-
cessful programs have been established in Pakistan, Egypt,10 Jordan,33
Lebanon,34 and Latin America.35 Ultimately, successful specialized
nursing education programs (from diagnosis through survivorship or
palliative care) are those with local ownership and integration in offi-
cially recognized nursing education systems.
In too many countries, nurses are rotated between departments
or for mandatory public health service,32,36 hindering achievement
of increasing competence and expertise.12 Pediatric oncology units
require a dedicated nursing team with knowledge and experience in
administering chemotherapy, monitoring side effects, managing oncol-
ogy emergencies, and providing patient/family education. Developing
this unique skill set is an inefficient investment unless arbitrary rota-
tionof nurses is stopped, becauseknowledgeandexpertise is lostwhen
nurses leave the unit. Nurse rotation also threatens retention and is a
serious issue in LMIC37 where nursing shortages are acute,38,39 specif-
ically in pediatric oncology units.
3 ETHICAL ARGUMENTATION FOR MORAL
ACTION
Historically, clinician exposure to health risks has been inherent to
communicable disease treatment and guiding ethical principles have
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TABLE 2 Ethical values as arguments for moral actions in
supporting health professionals in childhood cancer care, adapted
fromKass et al.40
Ethical values Moral actions
Respect It is imperative to acknowledge health professionals
for their willingness to undertake emotionally
distressing, highly advanced care, and potentially
risky tasks. The role of the specialist nurse in the
multidisciplinary childhood cancer care team
needs to be acknowledged and respected.
Protect from
harm
It is a duty to do no harm and to protect health
professionals, as well as patients/families, from
avoidable and preventable harm by providing
nurses and pharmacists with adequate training
and proper protective equipment.
Justice Imposition of reciprocal employer obligations to
protect employees from harm because health
professionals accept heightened risks as part of
their daily practice when handling hazardous
drugs andwhen providing care for which they do
not have proper training and education.
been articulated. Kass et al.40 write about key ethical concepts for
Ebola that are relevant for cancer care (Table 2).
Children/adolescents suffering from cancer in LMIC have the right
to curative treatment. However, it would be ethically questionable to
scale up diagnosis and treatment of childhood cancer as part of the
WHO Global Initiative for Childhood Cancer in LMIC, if the ability of
nurses and other health professionals to deliver such services safely
is ignored. Access to PPE for safe handling of chemotherapy and the
appropriate education and skills to deliver safe pediatric cancer care
are sine qua non. WHO Global Initiative for Childhood Cancer has
a crucial role in improving global access to appropriate childhood
cancer care; we argue it is an ethical imperative to ensure (a) adequate
protective equipment for all those handling hazardous drugs and (b)
that specialized pediatric oncology nursing education and nonrotation
of nurses is officially recognized, prioritized, and locally integrated
worldwide.
There has been a strong focus on standards of accountability for
health care in LMIC,9,41 but historically, a lack of prioritization, or even
neglect, of protectivemeasures fornurses andothershasbeenevident.
We must promote standards, identify incentives, and provide a solid
rationale to institutions and governments to prioritize access to PPE
for all those handling hazardous drugs, and, in parallel, advance spe-
cialized nursing roles and education to develop proficiency in pediatric
oncology nursing care and optimize patient outcomes.42
4 IMPLICATIONS
The Nurse Specialists of WHO Global Initiative for Childhood Cancer
urge WHO Member States and facilities delivering cancer treatment
to prioritize safe nursing work environments and specialized educa-
tion to improve overall population health. Health policy makers and
hospital administrators can improve nurse recruitment and retention
by creating a positive practice environment ensuring nurse occupa-
tional health and safety.43 Promoting such environments through safe
chemotherapy handling, specialized education, and nonrotation of
nurses in WHOMember States is essential to improve the safety and
outcomes of children/adolescents with cancer globally.
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